Because of naloxone’s ability to reverse opioid overdose and its ease of use, by July 15, 2017, all 50 states and the District of Columbia had passed legislation to improve naloxone access, as one strategy to reduce opioid overdose morbidity and mortality.
Image
Breadcrumb
- Home
- Resources and Tools
Resources and Tools
This Advisory offers guidance to providers and administrators in SUD treatment programs on screening clients for hepatitis A, hepatitis B, and hepatitis C infections, as well as action steps for the treatment and support of clients with a viral hepatitis infection and a SUD.
This webinar describes systemic barriers faced by patients with HIV and substance use disorders, and discusses steps providers can take to decrease these barriers and support integration of behavioral health and HIV public health interventions.